KALA BIO
KALA
82 hedge funds and large institutions have $33.7M invested in KALA BIO in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 35 reducing their positions, and 13 closing their positions.
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
9% more capital invested
Capital invested by funds: $30.9M → $33.7M (+$2.82M)
4% more funds holding
Funds holding: 79 → 82 (+3)
0% less ownership
Funds ownership: 0.02% → 0.01% (-0%)
54% less call options, than puts
Call options by funds: $79K | Put options by funds: $172K
71% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
+$723K |
| 2 |
GL
Graypoint LLC
Albany,
New York
|
+$511K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$183K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$147K |
| 5 |
Renaissance Technologies
New York
|
+$144K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$776K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$503K |
| 3 |
VAFP
Vahanian & Associates Financial Planning
Saratoga Springs,
New York
|
-$490K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$464K |
| 5 |
KOCAA
Knights of Columbus Asset Advisors
New Haven,
Connecticut
|
-$128K |
KALA Hedge Fund Activity: Q1 2022 in Review
82 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2022, worth a combined $33.7M — up 9.1% from $30.9M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new KALA positions and 13 closed out — a net gain of 3 holders — while 10 added to existing stakes and 35 trimmed.
The largest buyer was Board of Trustees of The Leland Stanford Junior University, opening a new position worth an estimated $723K. The largest seller was Pictet Asset Management (Switzerland), exiting entirely with an estimated $776K sold.
- 82 institutional investors held KALA BIO (KALA) as of Q1 2022, up from 79 in Q4 2021.
- Funds reported $33.7M of KALA BIO stock for Q1 2022, up 9.1% quarter-over-quarter.
- 16 funds opened new KALA BIO positions in Q1 2022 and 13 closed out, a net change of +3 holders.
- The largest KALA BIO buyer in Q1 2022 was Board of Trustees of The Leland Stanford Junior University, an estimated $723K added.
- The largest KALA BIO seller in Q1 2022 was Pictet Asset Management (Switzerland), an estimated $776K sold.
Based on aggregated 13F filings for Q1 2022.